Increased thrombogenicity is associated with revascularization outcomes in patients with chronic limb-threatening

Naoto Kuyama1, Koichi Kaikita2, Masanobu Ishii1

  • 1Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Insights

The atheroma chip test (AR10-AUC30) can predict revascularization after endovascular therapy in chronic limb-threatening ischemia (CLTI) patients. This suggests hypercoagulability contributes to CLTI progression, potentially benefiting from anticoagulant therapy.

Area of Science:

  • Vascular Medicine
  • Thrombosis Research
  • Interventional Cardiology

Background:

  • Clinically driven target lesion revascularization (CD-TLR) is common after endovascular therapy (EVT) for chronic limb-threatening ischemia (CLTI).
  • Quantitative thrombogenicity assessment using the total thrombus-formation analysis system (T-TAS) may predict CD-TLR.
  • Understanding T-TAS parameters' association with CD-TLR is crucial for optimizing CLTI management.

Purpose of the Study:

  • To investigate the association between T-TAS parameters and CD-TLR in patients undergoing EVT.
  • To determine if T-TAS can predict the need for revascularization in CLTI patients post-EVT.
  • To explore the role of hypercoagulability in CLTI progression and its impact on revascularization outcomes.

Main Methods:

  • Analysis of 34 CLTI patients and 62 non-CLTI patients who underwent EVT.
  • Measurement of platelet chip (PL24-AUC10) and atheroma chip (AR10-AUC30) parameters using T-TAS.
  • Clinical follow-up to assess CD-TLR, with statistical analysis including multivariable Cox regression and ROC curve analysis.

Main Results:

  • In CLTI patients, higher AR10-AUC30 was significantly associated with CD-TLR (P=.01).
  • AR10-AUC30 independently predicted CD-TLR in CLTI patients (HR, 2.04; P=.01).
  • An AR10-AUC30 cutoff of 1646 predicted CD-TLR with high sensitivity (0.93) and AUC (0.85).

Conclusions:

  • The AR10-AUC30 parameter from T-TAS shows potential for predicting CD-TLR in CLTI patients.
  • Hypercoagulability may play a significant role in CLTI progression.
  • Anticoagulant therapy could be beneficial in preventing revascularization in CLTI patients.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
35
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
38
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
52
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
39
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
42
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
50